相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prognostic Implications of MRI Melanin Quantification and Cytogenetic Abnormalities in Liver Metastases of Uveal Melanoma
Toulsie Ramtohul et al.
CANCERS (2021)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Uveal melanoma
Martine J. Jager et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab
Peter A. Johansson et al.
IMMUNOGENETICS (2019)
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Ernesto Rossi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations
Manuel Rodrigues et al.
CLINICAL CANCER RESEARCH (2019)
Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
Helen R. Davies et al.
NATURE COMMUNICATIONS (2019)
Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors
Manuel Rodrigues et al.
NATURE COMMUNICATIONS (2018)
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML
Mathijs A. Sanders et al.
BLOOD (2018)
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
Claire Mignard et al.
JOURNAL OF ONCOLOGY (2018)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review
Markus V. Heppt et al.
CANCER TREATMENT REVIEWS (2017)
Clinical Outcomes in Metastatic Uveal Melanoma Treated With PD-1 and PD-L1 Antibodies
Alain P. Algazi et al.
CANCER (2016)
Hypermutation in human cancer genomes: footprints and mechanisms
Steven A. Roberts et al.
NATURE REVIEWS CANCER (2014)
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy
N. Penel et al.
ANNALS OF ONCOLOGY (2013)
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group
S. Cousin et al.
ANNALS OF ONCOLOGY (2013)